Prostate Cancer - Results from #19840

Incorporation of detailed family history from the Swedish Family-Cancer Database into the Prostate Cancer Prevention Trial Risk Calculator - Abstract November 11, 2014

Relationships between times to testosterone and prostate-specific antigen rises during the first off-treatment interval of intermittent androgen deprivation are prognostic for castration resistance in men with nonmetastatic prostate cancer - Abstract November 11, 2014

Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy - Abstract November 11, 2014

Oncologic and quality-of-life outcomes with wide resection in robot-assisted laparoscopic radical prostatectomy - Abstract November 11, 2014

Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment - Abstract November 11, 2014

Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: Correlation with step-sectioned radical prostatectomy specimens in 135 patients - Abstract November 11, 2014

Development and assessment of an evidence-based prostate cancer intervention programme for black men: The W.O.R.D. on prostate cancer video - Abstract November 10, 2014

Outcomes of fecal carriage of extended-spectrum β-lactamase after transrectal ultrasound-guided biopsy of the prostate - Abstract November 10, 2014

Assessment of the bone scan index in a randomized placebo-controlled trial of tasquinimod in men with metastatic castration-resistant prostate cancer (mCRPC) - Abstract November 10, 2014

The importance of perceived stress management skills for patients with prostate cancer in active surveillance - Abstract November 8, 2014

The real practice of antibiotic prophylaxis for prostate biopsy in Korea where the prevalence of quinolone-resistant Escherichia coli is high - Abstract November 8, 2014

Trans-Pacific variation in outcomes for men treated with primary androgen deprivation therapy for prostate cancer - Abstract November 8, 2014

Diagnosis and management of local recurrence after low-dose-rate brachytherapy - Abstract November 8, 2014

Tissue composition and density impact on the clinical parameters for 125I prostate implants dosimetry - Abstract November 8, 2014

Long-term survival of extremely advanced prostate cancer patients diagnosed with prostate-specific antigen over 500 ng/ml - Abstract November 8, 2014

Quo vadis: Advanced prostate cancer-clinical care and clinical research in the era of multiple androgen receptor-directed therapies - Abstract November 8, 2014

From bench to bedside: The realities of reducing global prostate cancer disparity in black men - Abstract November 6, 2014

Defining a standard set of patient-centered outcomes for men with localized prostate cancer - Abstract November 6, 2014

Contemporary pharmacotherapy for the prevention of skeletal complications in patients with prostate cancer - Abstract November 6, 2014

Propensity-weighted long-term risk of urinary adverse events after prostate cancer surgery, radiation, or both - Abstract November 6, 2014

Page 993 of 1458